Viewing Study NCT04724018


Ignite Creation Date: 2025-12-25 @ 4:50 AM
Ignite Modification Date: 2026-03-01 @ 6:28 AM
Study NCT ID: NCT04724018
Status: RECRUITING
Last Update Posted: 2025-11-04
First Post: 2021-01-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Sacituzumab Govitecan Plus EV in Metastatic UC
Sponsor: Dana-Farber Cancer Institute
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module